Gilead's pipeline focuses on HCV, HIV, cardiovascular and respiratory disorders.
Drug Name | Description | Potential Indication | Testing Phase |
---|---|---|---|
Integrase Fixed-dose Regimen "Quad" | elvitegravir/FTC/TDF/cobicistat | HIV/AIDS | Phase III |
Truvada/TMC 278 Fixed-dose Regimen | Viread, Emtriva, and TMC 278 | HIV/AIDS | Phase III |
Elvitegravir (formerly GS-9137) | Integrase inhibitor | HIV/AIDS | Phase III |
Cobicistat (GS-9350) | Pharmacokinetic enhancer | HIV/AIDS | Phase III |
Tegobuvir (GS 9190) | Non-nucleoside polymerase inhibitor | Hepatitis C | Phase II |
Cicletanine | Antihypertensive | Pulmonary arterial hypertension | Phase II |
Aztreonam | inhalation solution | Bronchiectasis | Phase II |
Ranolazine | Late sodium current inhibitor | Coronary Artery Disease/Diabetes | Phase II |
GS 9256 | Protease inhibitor | Hepatitis C | Phase II |
GS 9310/11 | inhaled fosfomycin/tobramycin | Cystic Fibrosis/Chronic Obstructive Pulmonary Disease | Phase II |
GS 9667 (formerly CVT-3619) | Partial A1 adenosine agonist | Diabetes/Dyslipidemia | terminated |
GS 7340 | Nucleotide | HIV/AIDS | Phase I |
GS 9451 | Protease inhibitor | Hepatitis C | Phase I |
GS 5885 | NS5A inhibitor | Hepatitis C | Phase I |
GS 9620 | TLR-7 agonist | Hepatitis C/Hepatitis B | Phase I |
GS 6201 (formerly CVT-6883) | A2B adenosine antagonist | Pulmonary diseases | Phase I |
GS 6620 | Nucleotide polymerase inhibitor | Hepatitis C | Phase I |
Sofosbuvir (formerly GS 7977) | Nucleotide polymerase inhibitor | Hepatitis C | Phase III |
GS 9669 | Non-nucleotide polymerase inhibitor | Hepatitis C | pre-clinical |
GS 9411 | Epithelial sodium channel blocker | Pulmonary diseases | Phase I |
CVT-10216 | ALDH-2 inhibitor | Drug addiction | pre-clinical |
Tecadenoson | Selective A1 adenosine receptor | Atrial fibrillation | terminated |
Perfan | Enoximone | Heart failure | Phase III |
GS 9219 | Nucleotide analogue | Non-Hodgkin’s lymphoma and Chronic lymphocytic leukemia | Phase I |
GS 8374 | Protease inhibitor | HIV/AIDS | pre-clinical |
GS 424020 | Prodrug of Desisobutryl-ciclesonide and salmeterol | Asthma and Chronic obstructive pulmonary disease | pre-clinical |
GS 9148 | Nucleotide analog, phosphonomethoxy-2'-fluoro-2', 3'-dideoxydidehydroadenosine | HIV/AIDS | pre-clinical |
GS 9131 | Prodrug of GS 9148 | HIV/AIDS | pre-clinical |
GS 9224 | Integrase inhibitor | HIV/AIDS | pre-clinical |
GS 6624 | Humanized monoclonal antibody | idiopathic pulmonary fibrosis and advanced solid tumors | Phase I |
CAL-101 | PI3K Delta selective inhibitor | Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma | Phase I |
CAL-263 | PI3K Delta selective inhibitor | inflammatory diseases | Preclinical |
CAL-120 | PI3K Delta selective inhibitor | inflammatory diseases and oncology | Preclinical |
CAL-129 | PI3K Delta selective inhibitor | inflammatory diseases and oncology | Preclinical |
CAL-253 | PI3K Delta selective inhibitor | inflammatory diseases and oncology | Preclinical |
Read more about this topic: Gilead Sciences
Famous quotes containing the words product and/or pipeline:
“The end product of child raising is not only the child but the parents, who get to go through each stage of human development from the other side, and get to relive the experiences that shaped them, and get to rethink everything their parents taught them. The get, in effect, to reraise themselves and become their own person.”
—Frank Pittman (20th century)
“Even in the pink crib
the somehow deficient,
the somehow maimed,
are thought to have
a special pipeline to the mystical....”
—Anne Sexton (19281974)